Biopharmaceutica l Contract Manufacturing(BC
MO) Market
Biopharmaceutical Contract Manufacturing(BCMO)
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biopharmaceutical Contract Manufacturing(BCMO)
Market Size and Growth
The Biopharmaceutical Contract Manufacturing (BCMO) market research report indicates a steady growth in market conditions, driven by increasing demand for biopharmaceutical products. The global BCMO market size is projected to reach USD 18.2 billion by 2027, with a CAGR of 8.4% from 2020 to 2027.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Lonza Group Ltd
◍ Boehringher Ingelheim
◍ Sandoz
◍ Fujifilm Diosynth Biotechnology
◍ Rentschler Biotechnologie
◍ Celonic GmbH
◍ BIOMEVA GmbH
◍ ProBioGen AG
The Biopharmaceutical Contract Manufacturing (BCMO) market is highly competitive with key players like Lonza Group Ltd, Boehringer Ingelheim, Sandoz, Fujifilm Diosynth Biotechnology, Rentschler Biotechnologie, Celonic GmbH, BIOMEVA GmbH, and ProBioGen AG.
These companies offer contract manufacturing services to grow the BCMO market and generate significant sales revenues:
- Lonza Group Ltd: $5.5 billion
- Boehringer Ingelheim: $22.7 billion
- Sandoz: $7.9 billion
Request Sample Report
Market Segmentation
By Application
◍ Bio-Pharmaceutical Companies
◍ Pharmaceutical Companies
◍ Drug Discovery Companies
◍ Other
By Product
◍ Mammalian Based Manufacturing ◍ Microbial Based Manufacturing ◍ Other
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients